Literature DB >> 16231836

Real-time excitation-enhanced ultrasound contrast imaging.

Flemming Forsberg1, William T Shi, Michael K Knauer, Anne L Hall, Chris Vecchio, Richard Bernardi.   

Abstract

A new nonlinear contrast specific imaging modality, excitation-enhanced imaging (EEI) has been implemented on commercially-available scanners for real-time imaging. This novel technique employs two acoustic fields: a low-frequency, high-intensity ultrasound field (the excitation field) to actively condition contrast microbubbles, and a second lower-intensity regular imaging field applied shortly afterwards to detect enhanced contrast scattering. A Logiq 9 scanner (GE Healthcare, Milwaukee, WI) with a 3.5C curved linear array and an AN2300 digital ultrasound engine (Analogic Corporation, Peabody, MA) with a P4-2 phased array transducer (Philips Medical Systems, Bothell, WA) were modified to perform EEI on a vector-by-vector basis in fundamental and pulse inversion harmonic grayscale modes. Ultrasound contrast microbubbles within an 8 mm vessel embedded in a tissue-mimicking flow phantom (ATS Laboratories, Bridgeport, CT) were imaged in vitro. While video intensities of scattered signals from the surrounding tissue were unchanged, video intensities of echoes from contrast bubbles within the vessel were markedly enhanced. The maximum enhancement achieved was 10.4 dB in harmonic mode (mean enhancement: 6.3 dB; p = 0.0007). In conclusion, EEI may improve the sensitivity of ultrasound contrast imaging, but further work is required to assess the in vivo potential of this new technique.

Mesh:

Substances:

Year:  2005        PMID: 16231836     DOI: 10.1177/016173460502700201

Source DB:  PubMed          Journal:  Ultrason Imaging        ISSN: 0161-7346            Impact factor:   1.578


  1 in total

1.  Full experimental modelling of a liver tissue mimicking phantom for medical ultrasound studies employing different hydrogels.

Authors:  Sergio Casciaro; Francesco Conversano; Stefano Musio; Ernesto Casciaro; Christian Demitri; Alessandro Sannino
Journal:  J Mater Sci Mater Med       Date:  2008-12-04       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.